Selective Treatment of Solid Tumors Using Cold Atmospheric Plasma

CAPS Medical is a medical device company focused on development and commercialization of a minimally invasive and selective cancer treatment using Cold Atmospheric Plasma, applicable for a wide range of solid tumors.

CAPS Medical’s Benefits:

Deliver minimally invasive selective cancer treatment

Enable fine tuning of the delivered energy dose

Our Story

CAPS Medical was founded following extensive scientific research as a collaboration between the Technion’s Plasma Lab and Rambam Medical Center’s Cancer Lab, united in the fight against cancer. The company is addressing an unmet need in the multi billion dollar oncology therapeutics market.


Ilan Uchitel


Vast experience in leading complex products from concept to market in medical device and defense industries.

Jacob Cohen


Head of the Hearing and Voice institute, expert in endoscopic cancer surgery, Rambam Health Campus.

Avi Kayton

R&D Manager

Seasoned R&D manager with extensive  experience in developing  complex medical systems.

Supported by a panel of key scientific and clinical leaders

Contact us

For more information please contact